Biotech · Private company
Abivax S.A.
Track this companyFree. Adds Abivax S.A. to your Dealase workspace and tells you when its record changes.
Clinical trials62 recruiting or active
Pipeline programs6From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline6
- ABX464Phase 3 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- ABX196Phase 2 · Carcinoma, HepatocellularClinicalTrials.gov · fetched Nov 12, 2026
- ABX464 100 mgPhase 2 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- ABX464 25 mgPhase 2 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- ABX464 50 mgPhase 2 · Ulcerative ColitisClinicalTrials.gov · fetched Nov 12, 2026
- ObefazimodPhase 2 · Moderately to Severely Active Crohn DiseaseClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials6
- Efficacy and Safety of Obefazimod in Subjects With Moderately to Severely Active Crohn's DiseasePHASE2 · RECRUITING · started Oct 30, 2024ClinicalTrials.gov NCT06456593 · fetched Nov 12, 2026
- ABTECT-2 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -2PHASE3 · COMPLETED · started Jan 25, 2023ClinicalTrials.gov NCT05507216 · fetched Nov 12, 2026
- ABTECT - MaintenancePHASE3 · ACTIVE_NOT_RECRUITING · started Jan 16, 2023ClinicalTrials.gov NCT05535946 · fetched Nov 12, 2026
- ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1PHASE3 · COMPLETED · started Nov 16, 2022ClinicalTrials.gov NCT05507203 · fetched Nov 12, 2026
- ABX196 in Combination With Nivolumab in Patients With Hepatocellular CarcinomaPHASE1_PHASE2 · COMPLETED · started Feb 18, 2020ClinicalTrials.gov NCT03897543 · fetched Nov 12, 2026
- Dose-Ranging Phase 2b Study of ABX464 in Moderate to Severe Ulcerative ColitisPHASE2 · COMPLETED · started Aug 13, 2019ClinicalTrials.gov NCT03760003 · fetched Nov 12, 2026